OSE Immunotherapeutics Eulerpool Uudised

OSE Immunotherapeutics Eulerpool News

OSE Immunotherapeutics aktsia uudised

OSE Immunotherapeutics jälgivad paljud ajakirjanikud ja investorid üle kogu maailma. Kõige värskemad OSE Immunotherapeutics uudised paneme siia kokku.

• 16. aprill ·

  Yahoo
  OSE Immunotherapeutics’ Global License to Develop a Novel Monoclonal Antibody for the Treatment of Chronic Inflammation Becomes Effective
• 10. aprill ·

  Yahoo
  OSE Immunotherapeutics Receives €8.4 M in Public Funding to Support the Registration Phase 3 Clinical Trial of Cancer Vaccine Tedopi® in Lung Cancer
• 2. aprill ·

  Yahoo
  OSE Immunotherapeutics Announces Peer-Reviewed Publication on Novel Myeloid Immune Checkpoint CLEC-1 in Journal of Immunology
• 27. märts ·

  Yahoo
  OSE Immunotherapeutics Reports Full Year 2023 Financial Results and Provides Business Strategy Update
• 18. märts ·

  Yahoo
  OSE Immunotherapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial Evaluating Lusvertikimab in Patients with Ulcerative Colitis
• 29. veebruar ·

  Yahoo
  Pharma Stock Roundup: FDA Priority Tag to SNY, ABBV Filings, CHMP Nod for AZN, JNJ, MRK
• 28. veebruar ·

  Yahoo
  OSE Immunotherapeutics to Host a Live Webcast to Discuss AbbVie Global Partnership
• 28. veebruar ·

  Yahoo
  AbbVie and OSE Immunotherapeutics Announce Partnership to Develop a Novel Monoclonal Antibody for the Treatment of Chronic Inflammation
• 26. veebruar ·

  Yahoo
  OSE Immunotherapeutics Provides Update on Clinical Results With OSE-279 in Advanced Solid Tumors
• 19. jaanuar ·

  Yahoo
  OSE Immunotherapeutics Highlights Clinical Portfolio Advancements and Provides 2024 Outlook